Arcutis Biotherapeutics (NASDAQ: ARQT) reports vesting and insider sales in Form 144

Rhea-AI Filing Summary

Arcutis Biotherapeutics submitted a Form 144 notice reporting proposed sales of Common stock linked to restricted stock vesting. The filing lists vesting events of 5,152 shares (05/01/2025), 2,220 shares (11/14/2025), and 884 shares (05/01/2026). It also records sales of 3,325 shares on 02/27/2026 and 8,733 shares on 03/02/2026 with reported dollar amounts.

Key Figures

Sale on 02/27/2026: 3,325 shares Proceeds reported: 92,933.75 Sale on 03/02/2026: 8,733 shares +4 more

7 metrics

Sale on 02/27/2026 3,325 shares reported sale by Masaru Matsuda on 02/27/2026

Proceeds reported 92,933.75 dollar amount tied to 3,325-share sale on 02/27/2026

Sale on 03/02/2026 8,733 shares reported sale by Masaru Matsuda on 03/02/2026

Proceeds reported 220,938 dollar amount tied to 8,733-share sale on 03/02/2026

Restricted vesting 05/01/2025 5,152 shares Restricted Stock Vesting dated 05/01/2025

Restricted vesting 11/14/2025 2,220 shares Restricted Stock Vesting dated 11/14/2025

Restricted vesting 05/01/2026 884 shares Restricted Stock Vesting dated 05/01/2026

Key Terms

Restricted Stock Vesting, Common, Securities To Be Sold

3 terms

Restricted Stock Vesting financial

"Restricted Stock Vesting | Arcutis Biotherapeutics"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Common financial

"Common | Merrill Lynch 8890 Lyra Drive 5th Floor Columbus OH 43240"

Securities To Be Sold regulatory

"144: Securities To Be Sold"

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 8890 Lyra Drive 5th Floor Columbus OH 43240	8256	192415.53	124033382	05/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/01/2026	Restricted Stock Vesting	Arcutis Biotherapeutics			884	05/01/2026	NA
Common	05/01/2025	Restricted Stock Vesting	Arcutis Biotherapeutics			5152	05/01/2025	NA
Common	11/14/2025	Restricted Stock Vesting	Arcutis Biotherapeutics			2220	11/14/2025	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Masaru Matsuda 3027 Townsgate Rd Suite 300 Westlake Village CA 91361	Common	02/27/2026	3325	92933.75
Masaru Matsuda 3027 Townsgate Rd Suite 300 Westlake Village CA 91361	Common	03/02/2026	8733	220938

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does ARQT's Form 144 report about restricted stock vesting?

It lists specific restricted stock vesting events totaling several thousand shares across 2025–2026. The filing shows 5,152 shares vested on 05/01/2025, 2,220 shares on 11/14/2025, and 884 shares on 05/01/2026, all labeled "Restricted Stock Vesting."

How many shares and dollar amounts were reported sold in the past three months for ARQT?

The filing records two past sales: 3,325 shares and 8,733 shares. Those sales are listed with amounts of 92,933.75 and 220,938 respectively, tied to dates 02/27/2026 and 03/02/2026.

Who is the reporting party named in the Form 144 for ARQT?

The filing includes Masaru Matsuda as a reporting party with an address in Westlake Village, CA. The entry associates Mr. Matsuda with the two recent sales dated 02/27/2026 and 03/02/2026.

Does the Form 144 indicate the securities' exchange for ARQT shares?

Yes — the filing references NASDAQ as the exchange. The header shows an entry with NASDAQ and a date of 05/04/2026 alongside other securities details in the form.